Walleye Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.4K Sell
1,000
-200
-17% -$1.2K ﹤0.01% 4196
2025
Q4
$8.34K Buy
+1,200
New +$7.89K ﹤0.01% 4306
2025
Q1
Sell
-2,900
Closed -$23.4K 4278
2024
Q4
$23.4K Sell
2,900
-16,300
-85% -$134K ﹤0.01% 4482
2024
Q3
$157K Sell
19,200
-300
-2% -$1.98K ﹤0.01% 4163
2024
Q2
$136K Buy
19,500
+16,900
+650% +$128K ﹤0.01% 4553
2024
Q1
$27.6K Buy
+2,600
New +$22.7K ﹤0.01% 4841
2023
Q3
Sell
-400
Closed -$3.2K 4882
2023
Q2
$3.2K Buy
+400
New +$2.95K ﹤0.01% 4096
2023
Q1
Sell
-10,400
Closed -$65.3K 3940
2022
Q4
$65.3K Buy
+10,400
New +$72.6K ﹤0.01% 2471
2020
Q2
Sell
-19,200
Closed -$298K 622
2020
Q1
$298K Sell
19,200
-47,200
-71% -$1.14M 0.07% 343
2019
Q4
$1.99M Sell
66,400
-62,400
-48% -$1.62M 0.13% 200
2019
Q3
$2.81M Buy
128,800
+96,900
+304% +$2.22M 0.17% 142
2019
Q2
$805K Buy
31,900
+26,500
+491% +$629K 0.09% 334
2019
Q1
$133K Buy
+5,400
New +$129K 0.02% 924

Other funds holding BHC

Walleye Capital's BHC Position: Q1 2026 in Review

Walleye Capital increased its Bausch Health (BHC) stake by 8,380% in Q1 2026, buying an estimated $6.96M and bringing the position to 1,177,370 shares worth $6.36M. The position accounts for 0.03% of the portfolio, ranked #647.

Walleye Capital first reported a position in BHC in Q1 2019 and has held it in 11 quarters since. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Walleye Capital held 1,177,370 shares of Bausch Health worth $6.36M as of Q1 2026.
  • Walleye Capital bought 1,163,486 Bausch Health shares in Q1 2026, an estimated $6.96M.
  • Bausch Health made up 0.03% of Walleye Capital's portfolio in Q1 2026, its #647 holding.
  • Walleye Capital first reported a position in Bausch Health in Q1 2019 and has held it in 11 quarters since.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.